Hycamtin — United Healthcare
Merkel cell carcinoma
Initial criteria
- Diagnosis of Merkel cell carcinoma
- Disease is M1 disseminated
- Patient has a contraindication to or disease has progressed on anti-PD-L1 or anti-PD-1 therapy
Reauthorization criteria
- Patient does not show evidence of progressive disease while on Hycamtin therapy
Approval duration
12 months